How is acute myeloid leukaemia treated?

AML develops in the bone marrow and produces abnormal myeloid cells that interfere with healthy blood-cell production. Treatment commonly starts with chemotherapy, sometimes combined with targeted therapy chosen for a specific molecular feature. The aim may be to bring the leukaemia under control and restore healthy blood formation.

After initial treatment, further therapy may be given to reduce the chance of the leukaemia returning. An allogeneic stem cell transplant may be considered when the expected benefit fits the leukaemia’s risk features and the person’s fitness, donor options and preferences. Blood transfusions, infection treatment and other supportive care are part of the plan.

Attend appointments promptly and report fever, chills, bleeding, easy bruising, breathlessness or new weakness. Ask which medicines require precautions, how to care for a central line and when blood tests are needed. A haematology team can explain infection protection, transfusion support, fertility concerns and the expected sequence of treatment.

A fever during AML treatment can signal a serious infection and needs urgent medical advice, even if other symptoms are mild. Seek emergency help for uncontrolled bleeding, severe breathlessness, confusion, collapse, a severe headache or sudden weakness. Do not wait for the next planned appointment.

Ask which AML subtype and molecular findings were found, what the first treatment aims to achieve, how response will be checked, whether transplant is being considered, and which symptoms require immediate contact.